Amedisys (AMED) Misses Q3 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amedisys (AMED) Misses Q3 EPS by 8c

Mizuho Securities Upgrades Amedisys (AMED) to Buy; Sell-Off Excessive

November 7, 2016 7:48 AM EST

Mizuho Securities upgraded Amedisys (NASDAQ: AMED) from Neutral to Buy with a price target of $47.00, calling the sell-off after the COO resigned 'excessively overdone'.

Analyst Sheryl Skolnick commented, "AMED's shares dove Friday in concert with another C-Suite change at the... More

Amedisys (AMED) PT Cut to $47 at Mizuho Following Results

November 4, 2016 7:05 AM EDT

Mizuho Securities analyst Sheryl Skolnick reiterated a Neutral rating and lowered her price target on Amedisys (NASDAQ: AMED) to $47.00 following results.

Skolnick commented, "What the new team has done for AMED in a very short period of time seems close to a miracle... More